Light Heart® Intellectual Property HEARTBRAN® - U.S. Patent 'Fortified Rice Bran Food Product and Method for Promoting Cardiovascular Health' - issued August 20, 2002                                 European Patent - issued April 5, 2006                                Singapore Patent - issued February 28, 2006                                 Israel Patent - issued October 6, 2006                                 Australian Patent - issued June 21, 2007                                 Mexican Patent - issued November 5, 2007                                 Japanese Patent - issued April 24, 2009                                 Norwegian & Canadian Patent Pending   GUTBRAN® - US Patent 'Fortified Cereal Bran to Promote Digestive Health' - issued April 20, 2010                           Singapore Patent - issued June 15, 2010                           European & other patents pending

Light Heart LLC has completed a double-blind, placebo controlled clinical study of Heartbran in chocolate bars at Pennington Biomedical Center In Baton Rouge, Louisiana. A poster presentation of the study was presented by Katie Caruso of the LSU Human Ecology department at the Experimental Biology Meeting in San Diego on Monday, April 4, 2005 from 1:45 - 2:45PM. The abstract follows: A Rice Bran Bar Containing Omega-3 Fatty Acids and Vitamins Reduces Serum Homocysteine. Caruso MK*, Greenway FL**, Hoffpauer DW***. *LSU Human Ecology, **Pennington Center – LSU System, ***Light Heart LLC. A chocolate covered snack bar containing 14 grams of full fat rice bran, 6.25 mg thiamine, 125 mg ascorbic acid, 6.25 mg pyridoxine, 37.5 mcg cyanocobalamin, 50 units tocopherol, 0.125 mg folic acid, 500 mg of omega-3 fatty acids and 220 calories was compared to a placebo bar without vitamins, similar calories and corn starch/corn oil instead of rice bran/omega-3 fatty acids. Nine of 10 healthy subjects on no regular medications, 25-45 yr. (men), 25-55 yr. (women), LDL 130-190 mg/dl and triglycerides 150-300 mg/dl completed the randomized double-blind crossover trial with balanced order treatments. Subjects incorporated 6 bars/d in a weight maintaining diet. Homocysteine and lipids were drawn twice at the end of each 4-week treatment period and compared by paired t-test. Homocysteine decreased more during the rice bran bar period than during the placebo period (7.1 vs. 7.8 mcmol/L, p=0.028). Total cholesterol, LDL, triglycerides and c-reactive protein decreased more and HDL increased more during the rice bran bar period, but the changes were statistically insignificant. This bar for cardiovascular health decreased serum homocysteine, a recognized cardiovascular risk factor.